[go: up one dir, main page]

MX2009001925A - Composicion farmaceutica oral para uso en enfermedades respiratorias. - Google Patents

Composicion farmaceutica oral para uso en enfermedades respiratorias.

Info

Publication number
MX2009001925A
MX2009001925A MX2009001925A MX2009001925A MX2009001925A MX 2009001925 A MX2009001925 A MX 2009001925A MX 2009001925 A MX2009001925 A MX 2009001925A MX 2009001925 A MX2009001925 A MX 2009001925A MX 2009001925 A MX2009001925 A MX 2009001925A
Authority
MX
Mexico
Prior art keywords
pharmaceutical composition
oral pharmaceutical
respiratory diseases
composition
relates
Prior art date
Application number
MX2009001925A
Other languages
English (en)
Inventor
Raul Garcia Salgado Lopez
Juan Aurelio Senosiain Aguilar
Original Assignee
Senosiain S A De C V Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senosiain S A De C V Lab filed Critical Senosiain S A De C V Lab
Priority to MX2009001925A priority Critical patent/MX2009001925A/es
Priority to PCT/IB2009/007023 priority patent/WO2010094996A1/es
Priority to US13/202,743 priority patent/US20120064155A1/en
Priority to PE2011001495A priority patent/PE20120173A1/es
Priority to ARP100100462A priority patent/AR075058A1/es
Publication of MX2009001925A publication Critical patent/MX2009001925A/es
Priority to CR20110436A priority patent/CR20110436A/es
Priority to DO2011000267A priority patent/DOP2011000267A/es
Priority to HN2011002258A priority patent/HN2011002258A/es
Priority to CO11105852A priority patent/CO6410284A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a una composición farmacéutica oral de liberación modificada en cápsulas con microesferas, que contiene loratadina, fenilefrina y vehículos o excipientes farmacéuticamente aceptables; dicha composición presenta una biodisponibilidad inmediata, con valores de concentración plasmática dentro de la ventana terapéutica con una liberación uniforme y continua; se refiere también a un proceso de fabricación de la composición y al uso de dicha composición indicada para el tratamiento como antihistamínico y descongestionante nasal.
MX2009001925A 2009-02-20 2009-02-20 Composicion farmaceutica oral para uso en enfermedades respiratorias. MX2009001925A (es)

Priority Applications (9)

Application Number Priority Date Filing Date Title
MX2009001925A MX2009001925A (es) 2009-02-20 2009-02-20 Composicion farmaceutica oral para uso en enfermedades respiratorias.
PCT/IB2009/007023 WO2010094996A1 (es) 2009-02-20 2009-10-01 Composición farmacéutica oral para uso en enfermedades respiratorias
US13/202,743 US20120064155A1 (en) 2009-02-20 2009-10-01 Oral pharmaceutical composition for use in respiratory diseases
PE2011001495A PE20120173A1 (es) 2009-02-20 2009-10-01 Composicion farmaceutica oral que contiene loratadina y fenilefrina
ARP100100462A AR075058A1 (es) 2009-02-20 2010-02-17 Composicion farmaceutica oral para uso en enfermedades respiratorias y proceso de fabricacion
CR20110436A CR20110436A (es) 2009-02-20 2011-08-16 Composición farmacéutica oral para uso en enfermedades respiratorias
DO2011000267A DOP2011000267A (es) 2009-02-20 2011-08-19 Composicion farmaceutica oral para uso en enfermedades respiratorias
HN2011002258A HN2011002258A (es) 2009-02-20 2011-08-19 Composicion farmacéutica oral para uso en enfermedades respiratorias nuevo titulo tecnico: composición farmacéutica oral que contiene loratadina y fenilefrina. ( a petición de la oficina)
CO11105852A CO6410284A2 (es) 2009-02-20 2011-08-19 Composición farmacéutica oral para uso en enfermedades respiratorias

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2009001925A MX2009001925A (es) 2009-02-20 2009-02-20 Composicion farmaceutica oral para uso en enfermedades respiratorias.

Publications (1)

Publication Number Publication Date
MX2009001925A true MX2009001925A (es) 2010-08-20

Family

ID=42633450

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009001925A MX2009001925A (es) 2009-02-20 2009-02-20 Composicion farmaceutica oral para uso en enfermedades respiratorias.

Country Status (9)

Country Link
US (1) US20120064155A1 (es)
AR (1) AR075058A1 (es)
CO (1) CO6410284A2 (es)
CR (1) CR20110436A (es)
DO (1) DOP2011000267A (es)
HN (1) HN2011002258A (es)
MX (1) MX2009001925A (es)
PE (1) PE20120173A1 (es)
WO (1) WO2010094996A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2017003556A (es) 2014-09-19 2017-07-14 Procter & Gamble Formas de dosificacion de fenilefrina de liberacion pulsada.
MX391125B (es) * 2017-01-26 2025-03-21 Laboratorios Liomont S A De C V Composicion farmaceutica de loratadina, fenilefrina, paracetamol y amantadina para su administracion oral, para el tratamiento de alopatias relacionadas a un resfriado comun.
US10278930B2 (en) 2017-03-16 2019-05-07 The Procter & Gamble Company Method for relieving sinus congestion

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1255968B (it) * 1992-11-27 1995-11-17 Composizioni farmaceutiche contenenti acido ursodesossicolico
US20050152967A1 (en) * 2003-03-28 2005-07-14 Pfab, Lp Dynamic variable release
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
AU2007254821B2 (en) * 2006-06-01 2013-11-14 Bayer Consumer Care Ag Sustained release pharmaceutical formulation comprising phenylephrine
AR061165A1 (es) * 2006-06-01 2008-08-06 Schering Corp Formulaciones de liberacion pulsada de fenilefrina y composiciones farmaceuticas

Also Published As

Publication number Publication date
US20120064155A1 (en) 2012-03-15
DOP2011000267A (es) 2011-12-31
CR20110436A (es) 2011-10-24
AR075058A1 (es) 2011-03-09
CO6410284A2 (es) 2012-03-30
HN2011002258A (es) 2014-06-16
PE20120173A1 (es) 2012-03-24
WO2010094996A1 (es) 2010-08-26

Similar Documents

Publication Publication Date Title
WO2008131056A3 (en) Sustained release monoeximic formulations of opioid and nonopioid analgesics
MX2011013902A (es) Tratamiento de esclerosis multiple con laquinimod.
WO2008131057A3 (en) Sustained release formulations of opioid and nonopioid analgesics
MX2010005631A (es) Nuevos compuestos de hidrocarburo ciclicos para el tratamiento de enfermedades.
PL1765349T3 (pl) Opioidy do leczenia przewlekłej obturacyjnej choroby płuc (POChP)
PH12015500407B1 (en) Methods of treating hypertriglyceridemia
TWI369982B (en) Sustained release oral dosage forms of a prodrug of r-baclofen and methods of treatment
MY153092A (en) Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic
MX2009002196A (es) Oblea de buprenorfina para terapia de sustitucion de farmacos.
EA201100313A1 (ru) Способ доставки фармацевтической композиции пациенту, нуждающемуся в этом
WO2012007159A3 (en) Novel gastro-retentive dosage forms
WO2014064410A3 (en) Pharmaceutical composition comprising tiotropium and a hydrofluoroalkane
UA107578C2 (uk) Комбінована терапія при лікуванні діабету
PH12014502447A1 (en) Use of high dose laquinimod for treating multiple sclerosis
MY156302A (en) COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF ß-AMYLOID DISEASES AND SYNUCLEINOPATHIES
UA98136C2 (ru) Применение аклидиния для лечения респираторных заболеваний
IL215826A (en) Pharmaceutical preparation with delayed release, process of preparation of the preparation, use of the preparation for the preparation of pain medication and the pill containing it.
ATE302774T1 (de) Arzneimittel enthaltend betamimetika und ein neues anticholinergikum
AR091351A1 (es) Formulaciones de bromocriptina, metodo para mejorar el control glucemico y metodo para la fabricacion
EA201171087A1 (ru) СПОСОБЫ ВВЕДЕНИЯ (4aR,10aR)-1-н-ПРОПИЛ-1,2,3,4,4a,5,10,10a-ОКТАГИДРОБЕНЗО[g]ХИНОЛИН-6,7-ДИОЛА И РОДСТВЕННЫХ СОЕДИНЕНИЙ ЧЕРЕЗ СЛИЗИСТУЮ ОБОЛОЧКУ ПОЛОСТИ РТА, СЛИЗИСТУЮ ОБОЛОЧКУ НОСА ИЛИ КОЖУ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ НА ИХ ОСНОВЕ
MX341660B (es) Agonista del receptor de ghrelina para el tratamiento de caquexia.
MX2009001925A (es) Composicion farmaceutica oral para uso en enfermedades respiratorias.
NZ597957A (en) Otamixaban for treatment of elderly and renal impaired non-st elevation myocardial infarction patients
MX2010006317A (es) Composicion farmaceutica oral con antihistaminico y descongestionante.
ECSP11011279A (es) Composición farmacéutica oral para uso en enfermedades respiratorias

Legal Events

Date Code Title Description
FG Grant or registration